HC Wainwright reaffirmed their buy rating on shares of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) in a research note released on Friday,Benzinga reports. HC Wainwright currently has a ...

MSCs regulate many effector functions of innate immune cells, such as antigen presentation by dendritic cells (DCs ... into cells of the mesodermal lineage, such as adipocytes, osteocytes ...

an allogeneic cancer immunotherapy of antigen-presenting dendritic cells, which is in Phase I clinical trial to treat non-small cell lung cancer. Receive News & Ratings for Lineage Cell ...

Lineage Cell Therapeutics, Inc.’s LCTX share price has surged by 14.78%, which has investors questioning if this is right time to sell.

Various cell types contribute to dysregulation of immune responses in MDS. Dendritic cells (DCs) are important regulators of immunity. However, the role of DCs in MDS has yet to be elucidated.

"Although B cell lineage plasticity has been observed following ... 85% identified as monocytic or dendritic cells, which are ...